Papillary Thyroid Cancer

• CLINICAL_TRIALS trial_result · 2017-04-25
  Clinical Trial Update: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer [Phase 2]

  A Phase 2 trial evaluating sunitinib malate for iodine-refractory recurrent or metastatic thyroid cancer has completed enrollment and posted…

• CLINICAL_TRIALS research · 2016-03-31
  Clinical Trial Update: Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer [NA]

  This clinical trial update reports on a completed study evaluating carbon nanoparticles to guide central neck dissection in papillary thyroi…

• CLINICAL_TRIALS trial_result · 2015-11-05
  Clinical Trial Update: Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery [Phase 1]

  Phase 1 study evaluating the combination of Iodine-131 and Pazopanib in patients with recurrent or metastatic thyroid cancer that cannot be …

• CLINICAL_TRIALS trial_result · 2015-05-15
  Clinical Trial Update: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer [Phase 2]

  This Phase 2 trial of sorafenib tosylate in children and young patients with relapsed or refractory rhabdomyosarcoma, Wilms tumor, hepatocel…

• CLINICAL_TRIALS trial_result · 2014-09-01
  Clinical Trial Update: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 [Phase 2]

  Phase 2 clinical trial evaluating decitabine in iodine-refractory metastatic papillary or follicular thyroid cancer completed with results p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2014-06-25
  Clinical Trial Update: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy [Phase 2]

  Phase 2 trial evaluating bortezomib in metastatic thyroid cancer patients non-responsive to radioactive iodine; study completed with results…

• CLINICAL_TRIALS trial_result · 2014-05-06
  Clinical Trial Update: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer [Phase 2]

  Phase 2 trial of tanespimycin in patients with inoperable locoregionally advanced or metastatic thyroid cancer has completed with results po…

• CLINICAL_TRIALS trial_result · 2014-01-16
  Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer [Phase 2]

  Phase 2 trial of sorafenib tosylate in locally advanced, metastatic, or locally recurrent thyroid cancers was terminated.

• CLINICAL_TRIALS trial_result · 2013-12-19
  Clinical Trial Update: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine [Phase 2]

  Phase 2 trial evaluating romidepsin in patients with recurrent and/or metastatic thyroid cancer not responding to radioactive iodine; result…

• CLINICAL_TRIALS trial_result · 2012-01-13
  Clinical Trial Update: Prophylactic Central Neck Dissection for Papillary Thyroid Cancer [NA]

  A completed clinical trial evaluating prophylactic central neck dissection in papillary thyroid cancer. The study status is completed.

• CLINICAL_TRIALS trial_result · 2011-10-13
  Clinical Trial Update: Study of XL281 in Adults With Solid Tumors [Phase 1]

  Exelixis reports completion of a Phase 1 study of XL281 in adults with solid tumors, including non-small cell lung cancer, colorectal cancer…

• CLINICAL_TRIALS research · 2011-06-27
  Clinical Trial Update: Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid [NA]

  Pilot study using Technetium-99m MIBI SPECT-CT imaging for papillary thyroid cancer; the update provides no results or phase information.